Bryan Ball

CIK: 0001766522

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (37.5%)

Position reduction

Option Exercises (M)3 (18.8%)

Derivative conversions

Awards (A)7 (43.8%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

WHWK

Whitehawk Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

WHWK
Whitehawk Therapeutics, Inc.
Sep 15, 2026
Award(A)
Stock Option (right to buy)
Direct
91.6K shares-
WHWK
Whitehawk Therapeutics, Inc.
Sep 15, 2026
Award(A)
Restricted Stock Units
Direct
91.6K shares-
WHWK
Whitehawk Therapeutics, Inc.
May 14, 2026
Award(A)
Direct
51K shares at avg. $3.92$200K
WHWK
Whitehawk Therapeutics, Inc.
Apr 14, 2026
Sale(S)
Direct
92.5K shares at avg. $3.64$337K
WHWK
Whitehawk Therapeutics, Inc.
Apr 13, 2026
Sale(S)
Direct
26.4K shares at avg. $3.46$91K
WHWK
Whitehawk Therapeutics, Inc.
Apr 10, 2026
Sale(S)
Direct
6.6K shares at avg. $3.43$23K
WHWK
Whitehawk Therapeutics, Inc.
Apr 9, 2026
Sale(S)
Direct
50K shares at avg. $3.57$179K
WHWK
Whitehawk Therapeutics, Inc.
Apr 1, 2026
Award(A)
Stock Option (right to buy)
Direct
250.1K shares-
WHWK
Whitehawk Therapeutics, Inc.
Apr 1, 2026
Exercise(M)
Direct
366.5K shares-
WHWK
Whitehawk Therapeutics, Inc.
Mar 2, 2026
Sale(S)
Direct
1.8K shares at avg. $3.31$6K
WHWK
Whitehawk Therapeutics, Inc.
Mar 1, 2026
Exercise(M)
Direct
5K shares-
WHWK
Whitehawk Therapeutics, Inc.
Apr 1, 2025
Award(A)
Restricted Stock Units
Direct
366.5K shares-
WHWK
Whitehawk Therapeutics, Inc.
Apr 1, 2025
Award(A)
Stock Option (right to buy)
Direct
366.5K shares-
AADI
Aadi Bioscience, Inc.
Mar 4, 2025
Award(A)
Direct
100K shares at avg. $2.40$240K
AADI
Aadi Bioscience, Inc.
Mar 3, 2025
Sale(S)
Direct
2.1K shares at avg. $2.35$5K
AADI
Aadi Bioscience, Inc.
Mar 1, 2025
Exercise(M)
Direct
5K shares-

		Type	Shares	Price		Ownership
Sep 15, 2026	WHWK Whitehawk Therapeutics, Inc.	Award(A) Stock Option (right to buy)	91,633	-	-	Direct
Sep 15, 2026	WHWK Whitehawk Therapeutics, Inc.	Award(A) Restricted Stock Units	91,633	-	-	Direct
May 14, 2026	WHWK Whitehawk Therapeutics, Inc.	Award(A)	51,020	$3.92	$199,998	Direct
Apr 14, 2026	WHWK Whitehawk Therapeutics, Inc.	Sale(S)	92,460	$3.64	$336,554	Direct
Apr 13, 2026	WHWK Whitehawk Therapeutics, Inc.	Sale(S)	26,389	$3.46	$91,306	Direct
Apr 10, 2026	WHWK Whitehawk Therapeutics, Inc.	Sale(S)	6,596	$3.43	$22,624	Direct
Apr 9, 2026	WHWK Whitehawk Therapeutics, Inc.	Sale(S)	50,000	$3.57	$178,500	Direct
Apr 1, 2026	WHWK Whitehawk Therapeutics, Inc.	Award(A) Stock Option (right to buy)	250,058	-	-	Direct
Apr 1, 2026	WHWK Whitehawk Therapeutics, Inc.	Exercise(M)	366,532	-	$0	Direct
Mar 2, 2026	WHWK Whitehawk Therapeutics, Inc.	Sale(S)	1,834	$3.31	$6,070	Direct
Mar 1, 2026	WHWK Whitehawk Therapeutics, Inc.	Exercise(M)	5,000	-	$0	Direct
Apr 1, 2025	WHWK Whitehawk Therapeutics, Inc.	Award(A) Restricted Stock Units	366,532	-	-	Direct
Apr 1, 2025	WHWK Whitehawk Therapeutics, Inc.	Award(A) Stock Option (right to buy)	366,532	-	-	Direct
Mar 4, 2025	AADI Aadi Bioscience, Inc.	Award(A)	100,000	$2.40	$240,000	Direct
Mar 3, 2025	AADI Aadi Bioscience, Inc.	Sale(S)	2,147	$2.35	$5,045	Direct
Mar 1, 2025	AADI Aadi Bioscience, Inc.	Exercise(M)	5,000	-	-	Direct

1-16 of 16 transactions

About BALL BRYAN

BALL BRYAN (SEC CIK 0001766522) files insider reports with the SEC as Officer of Whitehawk Therapeutics, Inc. (WHWK).

Signal8 holds 9 ownership filings by BALL BRYAN, all Form 4s, filed between Mar 4, 2025 and Sep 18, 2026. Those filings report 16 transactions, from Mar 1, 2025 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BALL BRYAN's filings is in MORRISTOWN, NJ.

Recent filings by BALL BRYAN

Sep 15, 2026: Grants or awards of WHWK derivative securities (2 lines, Form 4, code A).
May 14, 2026: Grant or award of WHWK shares (Form 4, code A).
Apr 14, 2026: Open-market sale of WHWK shares (Form 4, code S).
Apr 13, 2026: Open-market sale of WHWK shares (Form 4, code S).
Apr 10, 2026: Open-market sale of WHWK shares (Form 4, code S).

Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)

Giacobello Scott M., CHIEF FINANCIAL OFFICER
Dornan David, Chief Scientific Officer
Lennon David James, CHIEF EXECUTIVE OFFICER
Dugan Margaret, Chief Medical Officer
Iyengar Vijay K, Director
Dalal Anupam, Director

How to read Form 4 transaction codes